T. Rowe Price Associates, Inc. 13D and 13G filings for ShockWave Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | ShockWave Medical, Inc. SWAV | T. Rowe Price Associates, Inc. | 1,012,393 2.800% | -2,064,859 (-67.10%) | Filing |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | ShockWave Medical, Inc. SWAV | T. Rowe Price Associates, Inc. | 3,077,252 8.700% | -861,765 (-21.88%) | Filing |
| 2021-04-12 2:07 pm Purchase | 2021-03-31 | 13G | ShockWave Medical, Inc. SWAV | T. Rowe Price Associates, Inc. | 3,939,017 11.300% | 1,458,245 (+58.78%) | Filing |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | ShockWave Medical, Inc. SWAV | T. Rowe Price Associates, Inc. | 2,480,772 7.200% | -93,074 (-3.62%) | Filing |